Searched for
NEEDLE FREE INJECTIONS
Cipla launches inhalable insulin for diabetes careCipla has launched a new orally inhaled insulin powder for diabetes patients in India. This needle-free alternative to injections offers a ...- Can injections be needle-free, painless? This Pune-based firm has the answerIntegriMedical has introduced a needle-free injection system (N-FIS) that eliminates the need for any prick or piercing, potentially allevi...
- Serum Partners US company to advance needle-free injection technologySII said, in a statement on Friday that the partnership with IntegriMedical aligns with its vision of 'Health for All' and IntegriMedical's...
- Serum Institute buys 20% stake in IntegriMedicalSerum Institute of India acquires 20% stake in IntegriMedical for N-FIS drug delivery solution. Adar Poonawalla envisions a needle-free vac...
- No more painful insulin shots: Hyderabad company develops oral insulin spray for diabetesHyderabad-based NiedlFree Technologies has developed a needle-free oral insulin spray called Ozulin, offering a painless alternative for di...
- mRNA booster vaccine Gemcovac-OM for Omicron launched at Rs 2,292/dose. Who can take and precautionsGemcovac-OM, the booster vaccine for Omicron from Emcure's subsidiary Gennova, had recently received the nod from the office of the Drug Co...
- Omicron-specific mRNA-based booster vaccine launchedIndia has developed its first indigenous mRNA vaccine, GEMCOVAC-OM, using platform technology developed by Gennova and funding from the Dep...
- Needle-free vaccine patches coming soon, say researchers and makersThe technique could help save children's tears at doctors' offices, and help people who have a phobia of syringes. Beyond that, skin patche...
- Zydus vaccine likely to cost Rs 300 a doseHealth secretary Rajesh Bhushan on Thursday had spoken about the pricing. "We are in conversation with the manufacturer. Since it is a thre...
- Government lab releases first batch of Zydus Cadila's covid vaccine ZyCoV-DNeedle-free ZyCoV-D, manufactured by Ahmedabad-based Zydus Cadila, is the first Covid-19 vaccine approved for the 12 to 18 years age group ...
- Cadila Healthcare Working on Needle-free, 2-Dose VaccineThe drug company is conducting phase-3 trials with over 20,000 participants to test whether its three-dose vaccine ZyCoV-D prevents virolog...
- Intranasal COVID vaccine candidate in early clinical stage of development in India: GovtMost vaccines are administered by injection through intramuscular or subcutaneous route.
- Covid has given syringe makers an unparalleled opportunity. And a prickly problemSyringe manufacturers are hopeful of meeting the demand arising out of the upcoming Covid vaccination programme, but a lack of clarity on t...
- Scientists design new oral capsule that may end the era of painful insulin jabsMany drugs, especially those made of proteins, cannot be taken orally because they are broken down in the gastrointestinal tract before the...
- Commonwealth Games 2018: Indians feel the sting as 'Syringegate' turns uglyThe Indian athletes have been cornered by the Australian Sports Anti-Doping Agency to give their samples on their arrival at the Athletes’ ...
- Scared of injections at the dentist? Needle-free method to deliver anaesthesia developedUsing tiny electric current to give anaesthesia, this methos could help save money and avoid contamination.
- A simple device could get rid of one of the most frustrating parts of living with diabetesOne of the most important things about helping people with diabetes better monitor their blood sugar levels is cutting out unnecessary step...
- Needle-free injectors: After anaesthesia, this could be the next great breakthroughA number of companies, including one called PharmaJet and another called BioJect, have developed needle-free injectors.
- Biocon to launch oral insulin drug by 2010Biotech company Biocon is planning to launch its oral insulin drug in India by 2010 and is targeting sales of Rs 500 crore from the domesti...
- Biocon to launch oral insulin drug by 2010Biotech company Biocon is planning to launch its oral insulin drug in India by 2010 and is targeting sales of Rs 500 crore from the domesti...
Load More
